Literature DB >> 16930770

The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.

E Robenshtok1, M Paul, L Leibovici, A Fraser, S Pitlik, I Ostfeld, Z Samra, S Perez, B Lev, M Weinberger.   

Abstract

Risk factors and outcomes for patients with nosocomial Acinetobacter baumannii bacteraemia were compared with those for patients with nosocomial Klebsiella pneumoniae bacteraemia in a single centre in Israel between 2000 and 2003. Data were collected retrospectively through patient chart review. In total, 112 patients with A. baumannii bacteraemia and 90 patients with K. pneumoniae bacteraemia were identified. A. baumannii was significantly associated with poorer performance status, mechanical ventilation, presence of devices, prior treatment with carbapenems, pneumonia as the source of infection and inappropriate empirical antibiotic treatment. All-cause 30-day mortality was higher for A. baumannii bacteraemia compared with K. pneumoniae bacteraemia (61.6% vs 38.9%, P=0.001). Variables significantly associated with mortality at the univariate level (P<0.1) were entered into a multi-variable logistic regression model for mortality. A. baumannii remained significantly associated with mortality when adjusted for all other risk factors (odds ratio 3.61, 95% confidence interval 1.55-8.39). This result did not change when the analysis was repeated for subgroups of less severely ill patients, i.e. those who were not ventilated and those who did not present with septic shock. These results support the view that nosocomial bacteraemia due to A. baumannii is associated with increased mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930770     DOI: 10.1016/j.jhin.2006.06.025

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  29 in total

1.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Prophage Hunter: an integrative hunting tool for active prophages.

Authors:  Wenchen Song; Hai-Xi Sun; Carolyn Zhang; Li Cheng; Ye Peng; Ziqing Deng; Dan Wang; Yun Wang; Ming Hu; Wenen Liu; Huanming Yang; Yue Shen; Junhua Li; Lingchong You; Minfeng Xiao
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

3.  Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.

Authors:  S Roy; R Viswanathan; A Singh; P Das; S Basu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-21       Impact factor: 3.267

4.  Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.

Authors:  John S Esterly; Milena Griffith; Chao Qi; Michael Malczynski; Michael J Postelnick; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

5.  Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.

Authors:  X Wang; L Zhang; A Sun; X Yang; W Sang; Y Jiang; J Cheng; J Wang; M Zhou; B Chen; J Ouyang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-18       Impact factor: 3.267

6.  Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents.

Authors:  Ebru Cakir Edis; Osman N Hatipoglu; Ozlem Tansel; Necdet Sut
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age.

Authors:  D Marchaim; R Zaidenstein; T Lazarovitch; Y Karpuch; T Ziv; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-05       Impact factor: 3.267

9.  Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006.

Authors:  Suzanne F Beavers; David B Blossom; Timothy L Wiemken; Kelly Y Kawaoka; Andrew Wong; Linda Goss; Malkanthie I McCormick; Douglas Thoroughman; Arjun Srinivasan
Journal:  Public Health Rep       Date:  2009 Nov-Dec       Impact factor: 2.792

10.  Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii.

Authors:  Mark D Adams; Karrie Goglin; Neil Molyneaux; Kristine M Hujer; Heather Lavender; Jennifer J Jamison; Ian J MacDonald; Kristienna M Martin; Thomas Russo; Anthony A Campagnari; Andrea M Hujer; Robert A Bonomo; Steven R Gill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.